Literature DB >> 33571263

Shedding and transmission of a live attenuated influenza A virus vaccine in pre-weaned pigs under field conditions.

Gustavo Lopez Moreno1, Jayaveeramuthu Nirmala1, Christa Goodell2, Marie Culhane1, Montserrat Torremorell1.   

Abstract

Influenza A virus (IAV) is one of the most important respiratory viruses affecting pig health and vaccination is the most common strategy to control influenza infections. In this field study we assessed the onset and duration of shedding of a live attenuated influenza virus (LAIV) vaccine, its ability to transmit to non-vaccinated pigs and whether the LAIV could be aerosolized and detected in the environment. Thirty-three litters (n = 33) of a farm using the LAIV vaccine were selected for the study, a subset of them (n = 12) were left unvaccinated and a subset of piglets (n = 3) in vaccinated litters were also left unvaccinated to serve as sentinels. Selected piglets from the litters were sampled multiple days post vaccination (DPV) by collecting nasal swabs and blood, and were tested using a LAIV vaccine specific RT-PCR assay and hemagglutination inhibition assay against the LAIV strains respectively. Environmental specimens consisting of air and surface wipes were also collected. One hundred percent (21/21) of the vaccinated litters tested LAIV positive 1 DPV and until 6 DPV. In contrast, only five (5/33) of the thirty-three non-vaccinated pigs tested positive during the course of the study. Viable LAIV was confirmed in vaccinated pigs by cell culture and whole genome sequencing. In addition, low levels of LAIV RNA (RT-PCR Ct values ranging between 33 and 38) were detected in all air specimens collected on the day of vaccination and until 6 DPV (3/10). Pigs had maternally derived antibodies reactive against the LAIV strains which may have influenced the degree of shedding observed. Under the conditions of this study, shedding of the LAIV from vaccinated pigs was limited in time, resulted in minimal transmission to non-vaccinated pigs and was detected in low levels in aerosols collected in the vaccinated rooms likely influenced by the presence of maternally derived antibodies against the LAIV strains.

Entities:  

Year:  2021        PMID: 33571263      PMCID: PMC7877771          DOI: 10.1371/journal.pone.0246690

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  22 in total

1.  Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.

Authors:  Amy L Vincent; Wenjun Ma; Kelly M Lager; Jürgen A Richt; Bruce H Janke; Matthew R Sandbulte; Philip C Gauger; Crystal L Loving; Richard J Webby; Adolfo García-Sastre
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

2.  Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection.

Authors:  K Van Reeth; G Labarque; S De Clercq; M Pensaert
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

Review 3.  Transmission of influenza A virus in pigs.

Authors:  M Torremorell; M Allerson; C Corzo; A Diaz; M Gramer
Journal:  Transbound Emerg Dis       Date:  2012-01-09       Impact factor: 5.005

4.  Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.

Authors:  Daniela S Rajão; Hongjun Chen; Daniel R Perez; Matthew R Sandbulte; Phillip C Gauger; Crystal L Loving; G Dennis Shanks; Amy Vincent
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

5.  Antigenic and genetic evolution of contemporary swine H1 influenza viruses in the United States.

Authors:  Daniela S Rajao; Tavis K Anderson; Pravina Kitikoon; Jered Stratton; Nicola S Lewis; Amy L Vincent
Journal:  Virology       Date:  2018-02-16       Impact factor: 3.616

6.  Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.

Authors:  Jee Hoon Lee; Marie René Gramer; Han Soo Joo
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

7.  Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.

Authors:  Amy L Vincent; Wenjun Ma; Kelly M Lager; Bruce H Janke; Richard J Webby; Adolfo García-Sastre; Jürgen A Richt
Journal:  Vaccine       Date:  2007-09-29       Impact factor: 3.641

8.  Real time reverse transcription (RRT)-polymerase chain reaction (PCR) methods for detection of pandemic (H1N1) 2009 influenza virus and European swine influenza A virus infections in pigs.

Authors:  Marek J Slomka; Anstice L E Densham; Vivien J Coward; Steve Essen; Sharon M Brookes; Richard M Irvine; Erica Spackman; Jonathan Ridgeon; Rebecca Gardner; Amanda Hanna; David L Suarez; Ian H Brown
Journal:  Influenza Other Respir Viruses       Date:  2010-09       Impact factor: 4.380

9.  Live attenuated influenza virus vaccine reduces virus shedding of newborn piglets in the presence of maternal antibody.

Authors:  Marika Genzow; Christa Goodell; Troy J Kaiser; Wesley Johnson; Marc Eichmeyer
Journal:  Influenza Other Respir Viruses       Date:  2018-02-04       Impact factor: 4.380

10.  Mathematical modeling of influenza A virus dynamics within swine farms and the effects of vaccination.

Authors:  Jennifer J H Reynolds; Montserrat Torremorell; Meggan E Craft
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

View more
  1 in total

1.  Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.

Authors:  Elien Vandoorn; Wojciech Stadejek; Anna Parys; Sharon Chepkwony; Koen Chiers; Kristien Van Reeth
Journal:  J Virol       Date:  2022-05-12       Impact factor: 6.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.